An ordinal tool is proposed to measure the full spectrum of functional outcomes following
COVID-19. This “Post-COVID-19 Functional Status (PCFS) scale” can be used for tracking …

Objective To report the clinicopathologic features and outcome of myositis in patients treated
with immune checkpoint inhibitors (ICIs) (irMyositis). Methods We retrospectively analyzed …

Objective To investigate the relevance of dysfunctional T cells in immune-mediated
myopathies. We analyzed T-cell exhaustion and senescence, in the context of programmed cell …

Designer receptors exclusively activated by designer drugs (DREADDs) derived from
muscarinic receptors not only are a powerful tool to test causality in basic neuroscience but also …

Health consequences that persist beyond the acute infection phase of COVID-19, termed
post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a …

Objective We aimed to estimate the incidence of cerebral sinus and venous thrombosis (CVT)
within 1 month from first dose administration and the frequency of vaccine‐induced …

Aim To characterise clinical presentation, laboratory and histopathologic characteristics and
assess the treatment and outcome of neuromuscular side-effects of checkpoint therapy. …

Purpose Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide
causing a global health emergency. Pa-COVID-19 aims to provide comprehensive data …

Background Neurological immune-related adverse events (irAE-n) are severe and potentially
fatal toxicities of immune checkpoint inhibitors (ICI). To date, the clinical significance of …

Chronic kidney disease (CKD) is now seen as a systemic disease involving also the central
nervous system [1], but the link between the kidney and different organ systems and disease …